Handelsavisen
prelaunch
Companies CCM
CC
CCM NYSE Unclassified

Concord Medical Services Holdings Ltd

$4,50
Open in Charts → Attach watcher ⌖
USD
Set alert
LatestTanzania opens Mbamba Bay port to boost Southern Africa trade
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
ROE
Net margin
Debt / equity
Beta
52w range
Volume
110
Day range
$4,71–$4,96
Prev close
$4,89
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

Concord Medical Services Holdings Ltd operates in the healthcare sector, providing medical services and solutions. The company generates revenue through its operations in this field.

Business. Concord Medical Services Holdings Ltd operates in the healthcare sector, providing medical services and solutions. The company generates revenue through its operations in this field.

Classification20 %
SectorUnclassified
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
not yet wired
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

1
  • MARKETSTanzania opens Mbamba Bay port to boost Southern Africa trade2026-07-18
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to CCM. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    Briefing · model-assisted

    Concord Medical Services Holdings Limited (CCM) is currently undergoing its first analysis, meaning there is no prior basis for computing material changes or deltas in its operational or financial metrics. Consequently, no specific events, numerical shifts, or strategic pivots can be identified from the available data to drive a narrative of change. The company’s current profile is characterized by minimal external engagement and visibility. Data indicates that CCM has only one listed officer, zero analyst coverage, and no membership in major indices. Furthermore, there are no identified top holders, suggesting a lack of significant institutional ownership or public tracking in the current dataset. Market sentiment and news activity have been entirely absent over the observed period. From June 27, 2026, through July 17, 2026, the daily dispatch count remained at zero, with no sentiment data recorded. This complete lack of news flow reinforces the status of the ticker as having no recent material developments or public discourse. Given the absence of material changes, watcher signals, or cross-source activity, the significance of CCM’s current state lies in its baseline status. Investors and analysts should note that the company lacks the typical markers of active market interest, such as analyst ratings or index inclusion, and has generated no recent news or sentiment signals. [doc:ccm-companyfacts]

    Signals & dispatch

    peak dispatch · 2026-07-18

    Composite-score breakdown

    Synthesis

    Business

    Concord Medical Services Holdings Ltd operates in the healthcare sector, providing medical services and solutions. The company generates revenue through its operations in this field.

    Classification20 %
    SectorUnclassified
    AI synthesis
    GENERATED

    Concord Medical Services Holdings Ltd's capital structure and liquidity position cannot be assessed due to the unavailability of financial snapshot data. The company's valuation snapshot indicates a market price of $3.95, but without additional financial metrics, a comprehensive analysis of its capital structure is not possible. The company's profitability and returns cannot be evaluated against industry_config preferred metrics or cohort medians, as no financial data is available for comparison. The segments and geographic exposure of the company are not disclosed, making it difficult to assess revenue concentration or geographic diversification. The growth trajectory of the company cannot be determined due to the lack of outlook numeric deltas and revenue history. Risk factors associated with the company are unknown, as the risk assessment indicates that no financial snapshot, source documents, or observations were available for this run. Recent events related to the company are limited to sparse public filing facts, with only text observations captured from recent filings.

    Concord Medical Services Holdings Limited (CCM) is currently undergoing its first analysis, meaning there is no prior basis for computing material changes or deltas in its operational or financial metrics. Consequently, no specific events, numerical shifts, or strategic pivots can be identified from the available data to drive a narrative of change. The company’s current profile is characterized by minimal external engagement and visibility. Data indicates that CCM has only one listed officer, zero analyst coverage, and no membership in major indices. Furthermore, there are no identified top holders, suggesting a lack of significant institutional ownership or public tracking in the current dataset. Market sentiment and news activity have been entirely absent over the observed period. From June 27, 2026, through July 17, 2026, the daily dispatch count remained at zero, with no sentiment data recorded. This complete lack of news flow reinforces the status of the ticker as having no recent material developments or public discourse. Given the absence of material changes, watcher signals, or cross-source activity, the significance of CCM’s current state lies in its baseline status. Investors and analysts should note that the company lacks the typical markers of active market interest, such as analyst ratings or index inclusion, and has generated no recent news or sentiment signals. [doc:ccm-companyfacts]

    Key takeaways
    • The company's financial and operational data is not available, limiting the ability to assess its performance.
    • The classification of the company is uncertain, with low confidence in its industry and sector placement.
    • The company's market price is known, but without additional financial metrics, a valuation analysis is not feasible.
    • The risk profile of the company cannot be evaluated due to the lack of financial and risk assessment data.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $4,50
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    Net cash
    Current ratio
    Debt / equity
    ROA
    ROE
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskUnknown
    Liquidity riskUnknown

    Benchmarks vs cohort

    No cohort benchmark data available for this issuer yet.

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Regulatory filings
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    Source documents
    • Concord Medical Services Holdings Ltd company facts · 2026-05-27

    Ownership & reference

    Leadership

    • Jianyu YangChairman of the Board, Chief Executive Officer

    Insider activity

    — missing data

    Short positioning

    3.0Kshares short-60.1% vs prior
    1days to cover
    37.9%short of daily vol
    402fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    CCMCanonical
    NYSE · USD

    Intel & risk

    peak dispatch · 2026-07-18
    OSINT findings
    Dilution riskUnknown
    Liquidity riskUnknown

    Evidence & claims

    From filings & derived data
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 68.8%Derived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): 1.6%Derived (calculated)
    • Revenue (YoY) (2025-12-31 vs 2024-12-31): 25.2%Derived (calculated)
    • EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 68.8%Derived (calculated)
    • Operating income (YoY) (2025-12-31 vs 2024-12-31): 48.7%Derived (calculated)
    • Gross profit (YoY) (2025-12-31 vs 2024-12-31): 134.0%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 3.7%Derived (calculated)
    • Long-term debt (YoY) (2025-12-31 vs 2024-12-31): -4.5%Derived (calculated)
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 47.0%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): 68.6%Derived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -4.0%Derived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 43.7%Derived (calculated)
    • Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): -2.0%Derived (calculated)
    • Net margin (FY 2025-12-31): -20.2%Derived (calculated)
    • Gross margin (FY 2025-12-31): 5.6%Derived (calculated)
    • Return on equity (FY 2025-12-31): 4.4%Derived (calculated)
    • Return on assets (FY 2025-12-31): -1.4%Derived (calculated)
    • Current ratio (FY 2025-12-31): 0.48xDerived (calculated)
    • Debt-to-equity (FY 2025-12-31): -2.23xDerived (calculated)
    • Capex (YoY) (2025-12-31 vs 2024-12-31): -61.0%Derived (calculated)
    • EPS (basic) (annual): USD-PER-SHARES -0SEC XBRL filing
    • Long-term debt (annual): USD 352.56MSEC XBRL filing
    • Current assets (annual): USD 134.69MSEC XBRL filing
    • Revenue (annual): USD 65.85MSEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-05-18FILINGFORM 6-K →
    2026-05-13FILINGFORM 6-K →
    2026-05-13FILINGFORM 6-K →
    2026-04-29FILING20-F filing →
    2026-04-15FILINGFORM 6-K →
    2025-12-02FILINGFORM 6-K →
    2025-09-30FILINGFORM 6-K →
    2025-09-26FILINGFORM 6-K →
    2025-08-28FILINGFORM 6-K →
    2025-07-29FILINGFORM 6-K →
    2025-07-22FILINGFORM 6-K →
    2025-07-14FILINGFORM 6-K →
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage